Skip to main content
. 2017 Mar 2;8(20):32783–32793. doi: 10.18632/oncotarget.15824

Table 4. Multivariate survival analyses of MMP-11 and clinicopathological parameters among patients with OSCC using the Cox regression model.

All cases (N=279) Hazard ratio (95% CI) p value
Clinical stage (stage I + II versus stage III + IV) 0.601 (0.202–1.788) 0.360
T status (T1 + T2 versus T3 + T4) 2.878 (1.150–7.204) 0.024*
N status (N0 versus N1 + N2 + N3) 4.655 (1.973–10.984) < 0.001*
Grade (Well versus moderate, poor) 1.662 (0.813–3.397) 0.164
MMP-11 (weak versus strong) 1.726 (1.017–2.930) 0.043*

* p value < 0.05 as statistically significant.